Startup postmortems — the essays founders write when the company dies — have accumulated into a genre with a dataset: hundreds of documented failures across cycles, from the 2014-2016 unicorn hangover through the 2022-2024 repricing. The single most cited cause of death is unoriginal: running out of money. But 'no market need' — the cause the postmortems name almost as often — and the cluster beneath it tell the truer story: the money runs out because of what happened upstream. These are the repeating lessons, from the documented record. Honey Badgers publishes information, not business advice.
Lesson one: no market need is the leading upstream cause
The consistent finding across postmortem collections: the largest share of failed startups died building something people did not need — not defeated by competitors, not outspent, simply unneeded. The postmortem phrasing repeats with eerie consistency: 'we built the product for eighteen months before seriously testing demand.' The antidote is equally repeated in the success literature: sell before building, charge early, treat the first ten customers as research funding. The failures cluster at the same point — teams whose engineering velocity substituted for market contact until the runway math intervened.
Lesson two: the burn that outran the story
The second repeating pattern, dominant in the 2021-2024 cohort: companies funded at expansion-market prices ran growth-market burn into a market that had stopped funding it. The documented mechanics: a burn multiple above 4-5x with no improving trend; sales teams hired before the motion repeated; the bridge round explored too late — with under three months of runway, every option is a bad one. The postmortems' consistent confession: the fundraising calendar was managed optimistically, with a raise start at four months of cash instead of the six-plus the market's own rules require. The lesson repeats because hope does.
Lesson three: co-founder conflict — the quiet killer
A stable share of postmortems across the decade name the founding team as the proximate cause: equity disputes that predated traction, role ambiguity that matured into deadlock, velocity mismatches that presented as strategic disagreements. The pattern's cruel detail: most of these companies had working products and some revenue — they died of governance, not market. The documented preventives, repeated in both literatures: vesting from day one, written role boundaries, and the uncomfortable early conversation about what happens if one founder's contribution changes — the mechanisms founders skip precisely because the relationship is good at the time they matter most.
Lesson four: single points of failure
The dependency deaths, growing in the recent record: the platform startup killed by an API policy change; the single-customer-dependent company killed by that customer's procurement cycle; the channel-dependent business killed by an algorithm update — and, the newest variant, the AI product killed when the model provider shipped its feature. The postmortems name the pattern honestly: concentration felt like focus right up until it was exposure. The preventive is architectural: no customer above a quarter of revenue without a plan, no platform dependency without a hedge, no roadmap whose moat is another company's forbearance — the same lesson the wrapper-versus-native test formalizes.
Lesson five: the pivot that came too late
The postmortems of companies that died holding a failing thesis share a signature: the signals — flat retention, contracts that would not close, the market event that invalidated the premise — were visible two to four quarters before the money ran out, and were absorbed into the narrative instead of acted on. The success literature's mirror image — the documented pivots that worked — is a story of acting with runway remaining. The repeating formulation: startups do not die from wrong theses; they die from holding wrong theses past the point where correction was affordable.
What the genre itself teaches
Two honest observations about the record. The postmortems are written by founders who tried — selection runs both directions, and the dataset overrepresents companies worth writing about. And the lessons are not learned in the sense of being prevented: each cycle's postmortems repeat the prior cycle's causes with updated vocabulary — 'no market need' becomes 'no product-market fit,' 'ran out of money' becomes 'could not raise in the new environment.' The causes are stable because they are structural: hope, time, and capital interact the same way in every cycle. The founders who read the genre seriously are not avoiding failure — nobody does — they are choosing which failure mode they can survive.
A decade of farewell essays compresses to a sentence: test demand before building, raise before you must, write down the founding deal, hedge your dependencies, and let go of the thesis while you can still afford a new one.
For more context, read Six Signals a Startup Should Pivot Before the Money Runs Out.
For more context, read solo founder vs co-founder.
For more context, read first ten customers b2b.